Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-17-032420

Chief Executive Officer acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Suzdak Peter David · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-08-16 Grant or award : show line 1 in the form +10,000 $1.99 $19,872 16,000 D
Loading xslF345X03/form4.xml…